INOVIO to release Q2 2026 financial results on August 12 with live webcast and Q&A.

INOVIO, a biotech company specializing in DNA medicines for HPV-related diseases and cancer, announced it will release its Q2 2026 financial results after market close on August 12, 2026. The company will hold a live webcast and conference call at 4:30 p.m. ET to discuss the results and provide a business update, including a live Q&A session with analysts. The webcast will be accessible online and archived for 90 days. This event is important for investors tracking INOVIO's progress in developing innovative DNA-based treatments.